Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-22-055143

General Counsel sold 699 shares at $12.88 ($9,003)

  • General Counsel acquired 1,924 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Ring Christine · General Counsel

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-10-30 Exercise or conversion : show line 1 in the form +1,924 6,884 D
2022-10-31 Sale : show line 2 in the form −699 $12.88 $9,003 6,185 D
Open-market sales · 699 sh · avg $12.88 · $9,003

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-10-30 Exercise or conversion : show line 3 in the form Restricted Stock Units −1,924 25,013 D
Loading xslF345X03/doc4.xml…